Myovant Sciences Stock Current Valuation
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
Valuation analysis of Myovant Sciences helps investors to measure Myovant Sciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Myovant Sciences' price fluctuation is very steady at this time. Calculation of the real value of Myovant Sciences is based on 3 months time horizon. Increasing Myovant Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Myovant stock is determined by what a typical buyer is willing to pay for full or partial control of Myovant Sciences. Since Myovant Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Myovant Stock. However, Myovant Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.98 | Real 22.9 | Hype 26.98 | Naive 26.97 |
The intrinsic value of Myovant Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Myovant Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Myovant Sciences helps investors to forecast how Myovant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Myovant Sciences more accurately as focusing exclusively on Myovant Sciences' fundamentals will not take into account other important factors: Myovant Sciences Company Current Valuation Analysis
Myovant Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Myovant Sciences Current Valuation | 2.6 B |
Most of Myovant Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myovant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Myovant Sciences has a Current Valuation of 2.6 B. This is 81.91% lower than that of the Biotechnology sector and 44.06% lower than that of the Health Care industry. The current valuation for all United States stocks is 84.37% higher than that of the company.
Myovant Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myovant Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Myovant Sciences could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics of similar companies.Myovant Sciences is currently under evaluation in current valuation category among its peers.
Myovant Fundamentals
| Return On Asset | -0.18 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.39) % | |||
| Current Valuation | 2.6 B | |||
| Shares Outstanding | 97.26 M | |||
| Shares Owned By Insiders | 48.61 % | |||
| Shares Owned By Institutions | 56.21 % | |||
| Number Of Shares Shorted | 8.39 M | |||
| Price To Earning | (8.56) X | |||
| Price To Book | 70.01 X | |||
| Price To Sales | 7.80 X | |||
| Revenue | 230.97 M | |||
| Gross Profit | 72.02 M | |||
| EBITDA | (183.89 M) | |||
| Net Income | (205.98 M) | |||
| Cash And Equivalents | 371.29 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 358.7 M | |||
| Debt To Equity | 138.60 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | (5.75) X | |||
| Cash Flow From Operations | (268.56 M) | |||
| Short Ratio | 11.21 X | |||
| Earnings Per Share | (1.92) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 579 | |||
| Beta | 2.15 | |||
| Market Capitalization | 2.62 B | |||
| Total Asset | 520.01 M | |||
| Retained Earnings | (811.83 M) | |||
| Working Capital | 123.03 M | |||
| Current Asset | 150.17 M | |||
| Current Liabilities | 27.14 M | |||
| Z Score | 2.8 | |||
| Net Asset | 520.01 M |
About Myovant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myovant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myovant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myovant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |